Table 4

Mortality and length of stay for intervention versus control patients

MortalityControl
n (%)
Intervention
n (%)
OR
(95% CI)
P valueAdjusted OR
(95% CI)*
P value
Transition bundle 1
 ICU13 (23.2)16 (25.8)1.2 (0.5 to 2.7)0.740.8 (0.3 to 2.2)0.72
 All-cause in-hospital15 (26.8)21 (33.9)1.4 (0.6 to 3.1)0.401.2 (0.5 to 3.2)0.68
 30 days†16 (36.4)15 (31.2)0.8 (0.3 to 1.9)0.600.7 (0.2. 1.8)0.41
Transition bundle 2
 ICU14 (21.5)12 (13.8)0.6 (0.3 to 1.4)0.210.4 (0.2 to 1.1)0.09
 All-cause in-hospital18 (27.7)19 (21.8)0.7 (0.4 to 1.5)0.400.7 (0.3 to 1.6)0.43
 30 days†12 (21.1)13 (18.6)0.9 (0.4 to 2.1)0.730.6 (0.2 to 1.7)0.37
Length of stayControl
Mean (SD)
Intervention
Mean (SD)
Adjusted difference (95% CI)‡P value
Transition bundle 1
 ICU10.8 (13.2)9.4 (8.0)−2.8 (−6.7 to 1.2)0.17
 In-hospital19.2 (19.4)18.6 (15.9)−2.3 (−8.7 to 4.2)0.49
Transition bundle 2
 ICU11.3 (11.2)9.3 (8.3)−1.8 (−4.9 to 1.2)0.24
 In-hospital19.8 (15.1)16.7 (10.2)−2.5 (−6.3 to 1.4)0.21
  • *Multivariable logistic regression model adjusted for age, sex, race/ethnicity, mechanical ventilation required, Acute Physiology and Chronic Health Evaluation (APACHE) II score and Charlson Comorbidity Index.

  • †Only state residents included as postdischarge data were acquired via the state All Payer’s Claims Database (APCD).

  • ‡Multivariable linear regression model adjusted for age, sex, race/ethnicity, mechanical ventilation required, APACHE II score and Charlson Comorbidity Index.

  • ICU, intensive care unit.